PortViewPortView
Nevro Corp. logo

Nevro Corp. (NVRO) Stock Analysis

NYSEHealthcareMedical - Devices

$5.84+0.00%
1-year price historyRange $3.29 – $13.59
52-week range$5.84
$3.17$13.30

What Nevro Corp. does

Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.

Key metrics

Market cap
$224.09M
P/E (TTM)
-1.91
EPS (TTM)
$-3.06
Beta
0.82
Dividend yield
0.00%
Revenue / share
$11.01
50-day avg
$5.63
200-day avg
$5.64
52-week high
$13.30
52-week low
$3.17
CEO
Kevin R. Thornal

ETFs linked to NVRO

Broad-market and Healthcare sector ETFs an investor holding Nevro Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NVRO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NVRO in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Nevro Corp.?
Nevro Corp. trades under the ticker NVRO on NYSE.
Which exchange is NVRO listed on?
NVRO is listed on NYSE.
What sector does Nevro Corp. operate in?
Nevro Corp. is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze NVRO in a portfolio?
PortView shows NVRO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.